Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Provide SNP Genotyping Services for GlaxoSmithKline

NEW YORK, June 29 – Illumina will provide SNP genotyping services on a set of samples provided by GlaxoSmithKline, the companies said Friday. 

The agreement calls for Illumina to apply its BeadArray technology to determine the frequency of specific SNPs in the GlaxoSmithKline samples. The companies did not disclose further details.

Illumina’s SNP scoring technology is based on a technique, developed together with Applied Biosystems, for attaching strands of DNA to beads, which are then placed in an indentation on the tip of a fiber optic bundle. The company arrays these bundles onto a cassette that matches up with a standard 96-well microtiter plate. 

Chevron has also commissioned Illumina to study how the BeadArray technology could be applied to detecting certain compounds in hydrocarbon processing operations.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.